Viewing Study NCT05195450


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-25 @ 2:33 PM
Study NCT ID: NCT05195450
Status: RECRUITING
Last Update Posted: 2022-02-28
First Post: 2022-01-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
Sponsor: Institute of Liver and Biliary Sciences, India
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module